Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists--in vitro experience
about
Assessment of platelet inhibition by point-of-care testing in neuroendovascular proceduresVariable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood.Monitoring antiplatelet therapy with point-of-care platelet function assays: a review of the evidence.Residual platelet reactivity: predicting short- and long-term clinical outcome in patients undergoing percutaneous coronary revascularization.Platelet function monitoring and clopidogrel.Platelet function tests for the monitoring of P2Y12 inhibitors.Prostacyclin receptor stimulation facilitates detection of human platelet P2Y(12) receptor inhibition by the PFA-100 system.The Role of Platelet Function Analyzer Testing in Cardiac Surgery Transfusion Management.Clopidogrel resistance: fact and fiction.Point-of-care platelet function testing in patients undergoing PCI: between a rock and a hard place.Utility of PFA-100 closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro.Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance.
P2860
Q26823633-C95B2DF0-8B89-4E08-AA46-E1EF47F7E81CQ30498026-22ED45CB-B28E-4B95-AA9F-A8639F1C5367Q37608580-69DE062B-2B80-4891-B93F-EC55A3B2B4D3Q37765291-7DA7931B-39E3-45CB-988A-3EF87DD0D034Q38068348-0ED8A5DD-1C69-456F-9D86-083141247691Q38089082-8ACE8B21-FA8A-4CD5-B24A-34E9600F593EQ39908656-0DCBD648-EA98-413A-86B9-F0958AC772E1Q40201873-C383422E-54F1-4913-BF77-740AA8B30467Q40347840-44870DCA-256F-4341-AEE9-60C8C9295309Q41349792-D111D423-40F6-4B17-922F-E4FF7DDF49CDQ46923683-FA1E390E-56B6-41BD-8408-34373A5E457EQ50676873-8E046C41-22EA-4933-AD5C-15057E603ED8Q54546944-6E7B2374-23E8-43EE-8B87-7F514DCF305B
P2860
Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists--in vitro experience
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Limited usefulness of the PFA- ...... tagonists--in vitro experience
@ast
Limited usefulness of the PFA- ...... tagonists--in vitro experience
@en
Limited usefulness of the PFA- ...... tagonists--in vitro experience
@nl
type
label
Limited usefulness of the PFA- ...... tagonists--in vitro experience
@ast
Limited usefulness of the PFA- ...... tagonists--in vitro experience
@en
Limited usefulness of the PFA- ...... tagonists--in vitro experience
@nl
prefLabel
Limited usefulness of the PFA- ...... tagonists--in vitro experience
@ast
Limited usefulness of the PFA- ...... tagonists--in vitro experience
@en
Limited usefulness of the PFA- ...... tagonists--in vitro experience
@nl
P2093
P2860
P356
P1476
Limited usefulness of the PFA- ...... tagonists--in vitro experience
@en
P2093
Cezary Watala
Jacek Golanski
Janina Baraniak
Justyna Pluta
P2860
P356
10.1515/CCLM.2004.006
P407
P577
2004-01-01T00:00:00Z